DULCOLAX SUPPOSITORY 10 MG [SIN02663P]

Product Info

DULCOLAX SUPPOSITORY 10 MG

[SIN02663P]

Indications
For use in patients suffering from constipation.
For preparation of diagnostic procedures, in pre and postoperative treatment and in conditions, which require defecation to be facilitated.

Dosage and Administration
Children aged 10 years or younger with chronic or persistent constipation should only be treated under the guidance of a physician.
Bisacodyl should not be used in children aged 4 years or younger.
Short-term treatment for constipation
Adults and children over 10 years: 1 to 2 coated tablets (5 – 10 mg) daily before bedtime, or 1 suppository (10 mg) for immediate effect.
Children 4 – 10 years: 1 coated tablet (5 mg) daily before bedtime
For preparation of diagnostic procedures and preoperatively
Should only be used under medical supervision.
Adults and children over 10 years: 2 coated tablets (10 mg) in the morning and 2 coated tablets (10 mg) in the evening and 1 suppository (10 mg) on the following morning is recommended.
When using DULCOLAX to prepare the patient for radiographic examination of the abdomen or employing it preoperatively, tablets should be combined with suppositories in order to achieve complete evacuation of the intestine.
In the management of constipation, once regularity has been restarted dosage should be reduced and can usually be stopped.
It is recommended to take the coated tablets at night to have a bowel movement the following morning. They should be swallowed whole with an adequate amount of fluid.
The coated tablets should not be taken together with products which reduce the acidity of the upper gastrointestinal tract, such as milk, antacids or proton pump inhibitors, in order not to prematurely dissolve the enteric coating.
Suppositories are usually effective in about 20 minutes (usual range 10 to 30 minutes).
Rarely the laxative effect has been reported 45 minutes after administration. They should be unwrapped and inserted into the rectum pointed end first. No specific information on the use of this product in the elderly is available. Clinical trials have included patients over 65 years and no adverse reactions specific to this age group have been reported.

Contraindications
DULCOLAX is contraindicated in patients with ileus, intestinal obstruction, acute abdominal conditions including appendicitis, acute inflammatory bowel diseases, and severe abdominal pain associated with nausea and vomiting which may be indicative of severe conditions.
DULCOLAX is also contraindicated in severe dehydration and in patients with known hypersensitivity to bisacodyl or any other component of the product.
DULCOLAX Suppositories should not be used when anal fissures or ulcerative proctitis with mucosal damage are present.